# New Biomarker for Alzheimer's Disease Diagnostic

> **NCT01315639** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1067 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **BIOLOGICAL:** biomarkers, MRI and CSF

## Key facts

- **NCT ID:** NCT01315639
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-03
- **Primary completion:** 2015-02-26
- **Final completion:** 2018-03-16
- **Target enrollment:** 1067 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01315639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01315639, "New Biomarker for Alzheimer's Disease Diagnostic". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01315639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*